← FDA Drug Approvals (Drugs@FDA)
EPTIFIBATIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SHUANGCHENG · Approved 2021-09-07
Drug application
- FDA Application #
ANDA213081- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- EPTIFIBATIDE
- Generic name
- EPTIFIBATIDE
- Active ingredients
- EPTIFIBATIDE
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- SHUANGCHENG
- Manufacturer
- Hainan Shuangcheng Pharmaceuticals Co., Ltd.
- First approval
- 2021-09-07
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown